![[xml]](xml.gif)
FeedsTOP STORIES FROM
AROUND THE WEB
- Justices Expand Rights to Experiment with Patented Drugs The New York Times
- Doctors Who Still Answer Your Calls The Los Angeles Times
- Barriers Keep Cancer Advances from Doctors AP/Newsday
- Getting Wired Could Help Predict Emotions The Boston Globe
- More than a Million in U.S. Live with HIV AP/Newsday
- U.S. to Review Heart Drug Intended for One Race The New York Times
- Surgical Tools Washed with Hydraulic Fluid AP/Newsday
TOP STORIES FROM OTHER
IDG PUBLICATIONS
- Judge Tosses Parts of Novell's Antitrust Suit Against Microsoft PC World
- IBM Sees Power Processor as Its Next Linux InfoWorld
- Nokia Switches to Open-Source Browser PC World
- Microsoft Picks Aruba for Next Generation WLAN NetworkWorld.com
- Time to Start Taking the Tablets? Techworld
- Inside Intel's Offerings Macworld
Advertisement
Featured WebcastAds By Google |
|
Featured Content
|
Infinium® Whole-Genome Genotyping
Analyzing Copy Number Variation with Infinium® Whole-Genome Genotyping |
Beverly Enterprises
How Beverly Enterprises realized a $6 million dollar ROI with new technology including HP Thin Clients |
Qumas - Total Cost of Ownership
REVEALED: 7 Total Cost of Ownership Truths to Consider When Deploying an Enterprise Compliance Management System |
Geospiza
Proven Methods for Removing Bottlenecks and Increasing the Capacity of Molecular Diagnostic Services |
|
|
|
|
|
Recent advances in genotyping technologies have enabled analysis of over 600,000 SNPs across large sample sets which have allowed whole-genome disease-association studies. More recently, several studies have shown the prevalence of common copy number variants encompassing a large percentage of the human genome. Illumina has developed the Infinium whole-genome genotyping assay, which can be applied to the study of genome-wide copy number variants and other alterations such as homozygosity tracts and how they relate to human disease. DOWNLOAD NOW |
How Beverly Enterprises realized a $6 million dollar ROI with new technology including HP Thin Clients. Beverly Enterprises, Inc's success is due in part to a focus on continual process improvement - always looking at ways of optimizing operations and making administrative functions more efficient. With that goal in mind Beverly Enterprises set out to streamline their technology platform. The result is a return-on-investment exceeding six million dollars while creating new technology efficiencies in relationship stability, customer service and reliability through the effective replacement of client and server equipment with solutions that included HP Thin Client. Download Now. DOWNLOAD NOW |
New white paper from QUMAS provides business managers in heavily regulated life sciences companies with a comprehensive guide to calculating Total Cost of Ownership (TCO) for selecting compliance solutions. The paper includes specific guidance in the form of “truths” as well as a TCO calculator template. Using these tools, you can build a best-in-class TCO model that will assist you in differentiating and analyzing enterprise-class compliance management solutions. DOWNLOAD NOW |
Geospiza, a trusted advisor to many of the world’s leading laboratories, releases white paper that describes in detail their confirmed approach for automating genetic testing. Download this free white paper to see how you can increase capacity by 4-fold or more without adding operational overhead. DOWNLOAD NOW |
Featured Events
- 4th Annual World Health Care Congress - April 22 - 24, Washington, DC
- AMIA Spring Congress - May 22 - 24, Orlando, FL
Sponsored Links
- Buy 3 Thin Clients, Get 1 Free!
- FDA compliant V&V for Medical Devices -- Free webinar
- The HP BladeSystem c-Class—power and performance make a dynamic duo.
- Professional Color Quality. Up to 30% Lower Cost Per Page. HP Officejet Pro K550. $199
- Drug Rehab
The CHI Network
For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA; (717) 399-1900 ext 100 or via email to [email protected].
©2002-2007 Bio-IT World Inc.
Privacy Policy
| March 14, 2007